Comparison of Nasal Taper-guard Cuffed and a Nasal Cylindrical Endotracheal Tube
NCT ID: NCT04503031
Last Updated: 2020-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2020-01-10
2020-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cylindrical tube group
The patient in cylindrical tube group (n=26) were intubated with cylindrical shaped endotracheal tube.
cylindrical endotracheal tube
endotracheal tube is intubated
tapergaurd tube group
The patient in taperguard tube group (n=26) was intubated with TaperGuard endotracheal tube.
TaperGuard endotracheal tube
TaperGuard endotracheal tube is intubated
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TaperGuard endotracheal tube
TaperGuard endotracheal tube is intubated
cylindrical endotracheal tube
endotracheal tube is intubated
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyungpook National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Younghoon Jeon
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Younghoon Jeon, Mr
Role: PRINCIPAL_INVESTIGATOR
kyungook national university hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyungpook National University Hospital
Daegu, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-11-043-001
Identifier Type: -
Identifier Source: org_study_id